GTMS Stock Price, Chart, Stats & News

Greenbrook TMS Inc., through its subsidiaries, manages a network of outpatient facilities across the United States that provide mental health services. These centers specialize in delivering Transcranial Magnetic Stimulation (TMS) therapy, an FDA-approved, non-invasive treatment for major depressive disorder and other mental health conditions, along with related psychiatric care. As of December 31, 2021, the company operated 94 wholly-owned and 55 TMS centers in various locations including Virginia, Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts.